0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Immune Function in the Elderly—Reply

Paul Carson, MD; Kristin L. Nichol, MD; Edward N. Janoff, MD
Arch Intern Med. 2001;161(3):482-483. doi:.
Text Size: A A A
Published online

Extract

In reply

We agree with Drs Hamer and Meydani that characterizing clinical immune responses in our ever-expanding advanced elderly population is of interest and importance. A number of the points that they raise were addressed in the "Comment" section of our article. Among the many parameters of immune function that can and have been tested in the elderly, we focused on B-cell function to characterize the ability of healthy older patients to produce antibodies in response to immunization. Our in vivo tests, such as determination of total immunoglobulin levels and antibody responses to vaccines, and of in vitro tests, such as measurement of responses to pokeweed mitogen (T-cell and T-cell– dependent B-cell responses) and Staphylococcus aureus Cowan strain 1 (a more T-cell–independent B-cell stimulus) reflects this focus. Because the literature suggests that both IL-2 production and responses to IL-2 may be impaired with aging, we compared B-cell responses to S aureus Cowan strain 1 with and without the exogenous T-cell–derived IL-2 to determine whether this cytokine would reverse any potential age-associated defects.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

February 12, 2001
Paul Carson, MD; Kristin L. Nichol, MD; Edward N. Janoff, MD
Arch Intern Med. 2001;161(3):482-483. doi:.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Microglial pathology. Acta Neuropathol Commun Published online Sep 26, 2014.;
Jobs
brightcove.createExperiences();